Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Integral Molecular $150K to ID Cancer Biomarkers

NEW YORK (GenomeWeb News) – Integral Molecular said today that the National Cancer Institute has awarded it a $150,000 contract to map epitopes for monoclonal antibodies directed against cancer biomarkers.

Integral, based in Philadelphia, will analyze protein targets of interest to the clinical cancer proteomics community using shotgun mutagenesis mapping technology to identify amino acids essential for antibody binding and to discover and characterize cancer-specific biomarkers.

During the first phase of the project, which is fully funded by NCI, Integral said it will epitope map antibodies generated against claudin membrane proteins involved in several types of cancer.

Shotgun mutagensis is a method for mapping epitopes by rapidly evaluating the effects of point mutations across an entire target protein. Using a patented high-throughput expression method, thousands of point mutations are simultaneously evaluated for functional protein activity, Integral said.

The approach is particular well-suited to cancer biomarkers, many of which are complex membrane proteins that are resistant to direct structural analysis, the company said.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.